This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Fragmin® (dalteparin sodium) prescribing information and adverse event reporting can be found at the bottom of the page.

Dosing: Unstable Angina and NSTEMI

Use of Fragmin in patients with unstable angina and non-ST-elevation MI

Indication:

Unstable angina and NSTEMI administered concurrently with aspirin1

Acute stage1

Dosage:

  • Recommended dose: 120 IU/kg body weight s.c. 12 hourly for up to 8 days
  • Max dose: 10,000 IU/12 hours

Extended use:

  • Fragmin may be used beyond 8 days (i.e. for those awaiting angiography/revascularisation procedures). To be given until the day of revascularisation procedure, percutaneous transluminal coronary angioplasty [PTCA] or coronary artery bypass graft [CABG]) but not for >45 days

Recommended dose in extended use:1​​​​​​​

Unstable Angina and NSTEMI

Using Fragmin Needle-Trap

Click below to learn how to use a Fragmin Needle-Trap

Learn more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No